| Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia (>>
click to go to the journal's website) Human Psychopharmacology: Clinical and Experimental, 12/01/09 |
Suzuki T et al. – While these preliminary results need to be tested against tenacious monotherapy or polypharmacy involving clozapine, augmenting atypical antipsychotics with valproic
acid can be useful for very severe schizophrenia.Receive more summaries like this by joining MDLinx. We provide free daily digests of top journal articles in your field. >> Click here to choose your specialties. |
Other articles in Psychiatry>> Click here to see the complete listMedicare cracks
down on false claims 2009 earnings
survey: How do you compare An algorithm for
the pharmacological treatment of depression |
No comments:
Post a Comment